Buscar
Mostrando ítems 1-10 de 313
Beta-lactamase detection in Staphylococcus aureus and coagulase-negative Staphylococcus isolated from bovine mastitis
(Colégio Brasileiro de Patologia Animal - CBPA, 2014-04-01)
The objectives of the study were to evaluate the presence/production of beta-lactamases by both phenotypic and genotypic methods, verify whether results are dependent of bacteria type (Staphylococcus aureus versus ...
Beta-lactamase detection in Staphylococcus aureus and coagulase-negative Staphylococcus isolated from bovine mastitis
(Colégio Brasileiro de Patologia Animal - CBPA, 2014)
Beta-lactamases de espectro ampliado (ESBL) produzido por enterobactérias: mecanismo de ação, diagnóstico e controle
(Universidade Federal de Minas GeraisUFMG, 2015-03-16)
The antimicrobial resistance has increased in Brazil and wordwide in the last years. The extended spectrum beta-lactamases (ESBL) is an important mechanism among a great variety of resistance mechanisms. This study is aimed ...
Estudo in silico da diversidade entre enzimas responsáveis pela resistência bacteriana a diferentes classes de antimicrobianos com foco principal em beta-lactamases
(2018)
Bactérias podem se tornar resistentes à ação dos antibióticos por diferentes mecanismos, mas a produção de enzimas inativadoras é considerada o mecanismo mais eficiente e capaz de se disseminar com maior facilidade. Dentre ...
Understanding the Covalent binding of Clavulanate against beta-lactamases (TEM-1 and KPC-2) with QM/ MM methods.
(2017)
β-lactamases are a primary cause of bacterial resistance to β-lactam antibiotics for many important human pathogens
(particularly Gram-negative bacteria) (Hermann, Pradon, Harvey, & Mulholland, 2009). Inhibitors of ...
Understanding the covalent inhibition of Clavulanate against beta-lactamases (TEM-1 and KPC-2) with QM/MM screening methods
(2017)
important human pathogens (particularly Gram-negative bacteria) [1]. Inhibitors of β-lactamase
have been implemented as a dual therapy with antibiotics, but there are only four inhibitors
clinically approved and resistance ...